Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 18, 2021 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference

ALACHUA, Fla. and TAMPA, Fla., May 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to...
May 06, 2021 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference

ALACHUA, Fla. and TAMPA, Fla. , May 06, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity...
May 05, 2021 16:00 ET | Source: Axogen, Inc.

Axogen, Inc. Reports 2021 First Quarter Financial Results

ALACHUA, Fla. and TAMPA, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
April 14, 2021 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report First Quarter Financial Results and Host Conference Call on May 5, 2021

ALACHUA Fla. and TAMPA, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to...
March 01, 2021 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Promotes Peter J. Mariani to Executive Vice President and Chief Financial Officer

ALACHUA, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
February 22, 2021 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Reports 2020 Fourth Quarter and Full-Year Financial Results

ALACHUA, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported...
February 18, 2021 07:00 ET | Source: Axogen, Inc.

Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis

ALACHUA, Fla., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
February 04, 2021 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Participate at Upcoming February Investor Conferences

ALACHUA, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
February 01, 2021 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call on February 22, 2021

ALACHUA, Fla., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
January 11, 2021 07:00 ET | Source: Axogen, Inc.

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2020

ALACHUA, Fla., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right